Home

News

Novartis AG v (1) Focus (2) Actavis [2016] EWCA Civ 129521 December 2016Daniel Alexander QC and Henry Ward successfully represented the respondents, Focus and Actavis, in the first of two linked appeals concerning Novartis’ patent for a transdermal patch to deliver the drug Rivastigmine. Daniel Alexander QC and Mark Chacksfield represented the respondent, Teva, in the second appeal, on which the parties reached a settlement before the […]
Novartis AG v Focus Pharmaceuticals UK Ltd21 December 2016Daniel Alexander QC and Henry Ward successfully represented the respondents, Focus and Actavis, in the first of two linked appeals concerning Novartis’ patent for a transdermal patch to deliver the drug Rivastigmine. Daniel Alexander QC and Mark Chacksfield represented the respondent, Teva, in the second appeal, on which the parties reached a settlement before the […]
Teva v Boehringer Ingelheim [2016] EWCA Civ 129616 December 2016Daniel Alexander QC and Mark Chacksfield appeared for the Respondent, Teva, in Boehringer’s application for permission to appeal a decision that its patent for formulating inhaler capsules for the drug tiotroprium bromide was invalid. The patent concerned the use of hydroxypropyl methyl cellulose (HPMC) to enable a drier formulation of inhaler capsules than that obtainable […]
Teva UK LTD v Boehringer Ingelheim Pharma GMBH & Co KG [2016] EWCA Civ 129616 December 2016Daniel Alexander QC and Mark Chacksfield appeared for the Respondent, Teva, in Boehringer’s application for permission to appeal a decision that its patent for formulating inhaler capsules for the drug tiotroprium bromide was invalid. The patent concerned the use of hydroxypropyl methyl cellulose (HPMC) to enable a drier formulation of inhaler capsules than that obtainable […]
Action Storage v G-Force Europe [2016] EWHC 3151 (IPEC)7 December 2016Jessie Bowhill won a convincing victory for the claimant in a two day IPEC trial relating to unregistered design rights subsisting in the shape and configuration of plastic lockers. The Judgment is notable for the comments of the Judge concerning future conduct of unregistered design right cases and in particular his recommendation that litigants prepare […]
Action Storage Systems Ltd v G-Force Europe [2016] EWHC 3151 (IPEC)7 December 2016Jessie Bowhill won a convincing victory for the claimant in a two day IPEC trial relating to unregistered design rights subsisting in the shape and configuration of plastic lockers. The Judgment is notable for the comments of the Judge concerning future conduct of unregistered design right cases and in particular his recommendation that litigants prepare […]
Jaani Riordan speaks at CIPIL1 December 2016“Hyperlinking and website blocking injunctions: recent copyright case law from the European and English courts” Jaani’s lecture critically evaluated recent case law concerning internet copyright infringement and online intermediaries. Its focus will be the decision of the CJEU in GS Media BV v Sanoma Media Netherlands BV (Case C-160/15, EU:C:2016:644), which concerns the liability of […]
Hospira v Genentech [2016] EWCA Civ 118530 November 2016Michael Tappin QC and Mark Chacksfield appeared on behalf of the appellant, Genentech, and Richard Meade QC appeared on behalf of Respondent, Hospira, in this appeal against revocation of Genentech’s patent for a method of treating breast cancer. The patent claimed the use of antibodies against the oncogene Erb2 (including the drug known as Herceptin) […]
R (British American Tobacco UK Limited & Ors) v Secretary of State for Health [2016] EWCA Civ 118230 November 2016Martin Howe QC and Jaani Riordan appeared on behalf of the Secretary of State, and Lindsay Lane appeared on behalf of Imperial Tobacco Limited, in four linked appeals from Green J’s dismissal of claims for judicial review of the Standardised Packaging of Tobacco Products Regulations 2015 (‘Regulations‘). The Regulations require the surfaces of cigarette packs […]
Hospira UK LTD v Genentech INC [2016] EWCA Civ 118530 November 2016Michael Tappin QC and Mark Chacksfield appeared on behalf of the appellant, Genentech, and Richard Meade QC appeared on behalf of Respondent, Hospira, in this appeal against revocation of Genentech’s patent for a method of treating breast cancer. The patent claimed the use of antibodies against the oncogene Erb2 (including the drug known as Herceptin) […]